ID   PFHR-9
AC   CVCL_3566
SY   PFHR 9; PFHR9; PF HR-9
DR   CLO; CLO_0008424
DR   EFO; EFO_0022817
DR   ATCC; CRL-2423
DR   Wikidata; Q54947251
RX   PubMed=558822;
RX   PubMed=1917782;
CC   Characteristics: Not tumorigenic when injected subcutaneously into 129/Sv mice (ATCC=CRL-2423).
CC   Doubling time: 12 hours (ATCC=CRL-2423).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5911 ! PCC4-F
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
RX   PubMed=558822;
RA   Chung A.E., Estes L.E., Shinozuka H., Braginski J., Lorz C.,
RA   Chung C.A.;
RT   "Morphological and biochemical observations on cells derived from the
RT   in vitro differentiation of the embryonal carcinoma cell line PCC4-F.";
RL   Cancer Res. 37:2072-2081(1977).
//
RX   PubMed=1917782; DOI=10.1007/BF02631108;
RA   Speth C., Epplen J.T., Oberbaumer I.;
RT   "DNA fingerprinting with oligonucleotides can differentiate cell lines
RT   derived from the same tumor.";
RL   In Vitro Cell. Dev. Biol. Anim. 27:646-650(1991).
//